The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...